Esteban, D
Tovar, N
Jiménez, R
Santacruz, R
Baumann, T
Pastor, MaC
de la Riva, A
Carrera, E
Chaves, S
Royo, C
Navarro, A
Rodríguez, S
Ayuso, C
Riu, G
Creus, N
Gómez, B
Giné, E
López-Guillermo, A
Delgado, J
Article History
First Online: 2 October 2015
Competing interests
: JD has received consulting and lecturing fees from Gilead, Janssen, GSK-Novartis, Roche and Celgene. JD has also received research grants from GSK and Roche. The remaining authors declare no conflict of interest.